Cancer

Yale Cancer Center embraces a tradition of innovative cancer treatment and quality care. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 51 such centers in the United States. Cancer care is available to patients and families through Smilow Cancer Hospital and the Smilow Cancer Hospital Network through multidisciplinary teams who work together to make sure that every aspect of a patient’s treatment plan is personalized and well managed. Smilow Cancer Hospital is accredited by the Commission on Cancer, a Quality program of the American College of Surgeons, and recognized by the American Society of Clinical Oncology with a Quality Oncology Practice Initiative (QOPI) certification.

A world leader in cancer care, research, and education, Yale Cancer Center delivers the transformative scientific discoveries and care innovations of Smilow Cancer Hospital and Yale School of Medicine to bring us closer to a world free of cancer–one patient at a time. Recent advances in immunotherapy to treat certain cancers have been transformational, and Yale Cancer Center and Smilow Cancer Hospital are leaders in the cancer immunotherapy revolution.

Members of six cancer research programs led 793 scientific publications in 2021, generating new data, new discussions, and new outcomes to meaningfully improve the course of cancer care. The collaborations between Yale Cancer Center’s research programs and Smilow Cancer Hospital’s clinical centers are advancing innovations from laboratories to benefit patients while, at the same time, bringing data back to inform future laboratory discoveries. Over the next five years, this momentum will strengthen, further positioning Yale Cancer Center and Smilow Cancer Hospital as national and international leaders in cancer research and care, while also tackling issues of disparities and inequities in our community.